Description
An adenosine A2 receptor antagonist (Ki = 1.7 nM for the human receptor); inhibits adenosine-induced cAMP production in CHO cells expressing the human A2 receptor (IC50 = 0.79 μM); reverses NECA-induced suppression of IFN-γ secretion in CD8+ T cells; reduces tumor growth when administered alone and in combination with checkpoint inhibitors in syngeneic mouse tumor models
Formal name: 6-(2-chloro-6-methyl-4-pyridinyl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine
Synonyms: HTL-1071
Molecular weight: 315.7
CAS: 1321514-06-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer